Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% |
|
0.00% | 0.00% |
2020 | Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019 | CI |
2019 | Abattis Bioceuticals Corp. Announces Board Changes | CI |
Quotes 5-day view
Delayed Quote OTC Markets26/06/2024 | 02/07/2024 | |
---|---|---|
Last | 1.0E-6 $ | 1.0E-6 $ |
Volume | 500 | 10 000 |
Change | +∞% | 0.00% |
Opening | 0.00 | 0.00 |
High | 0.00 | 0.00 |
Low | 0.00 | 0.00 |
Volumes
marketsBasic data
Highs and lows
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Medical Farming
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | - | - | 476 | ||
0.00% | -13.65% | +4.12% | +120.00% | 209M | ||
0.00% | -10.42% | -11.34% | +38.71% | 183M | ||
-2.37% | +1.98% | +19.77% | +3.00% | 156M | ||
-.--% | -.--% | +300.00% | +166.67% | 121M | ||
0.00% | -20.00% | -42.86% | -20.00% | 96.6M | ||
-1.72% | -12.47% | +21.74% | +16.67% | 110M | ||
+1.26% | -5.48% | +66.70% | +24.10% | 92.14M | ||
-3.68% | +2.81% | -59.32% | -57.93% | 85.95M | ||
-4.76% | -23.08% | -23.08% | -50.00% | 70.16M | ||
Average | -1.13% | +9.49% | +30.64% | +26.80% | ||
Weighted average by Cap. | -0.97% | +10.03% | +31.77% | +41.25% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|---|---|---|
17:15:14 | 0.000001 | 10,000 | 20,000 |
Monthly variations
Annual change
2024 | 0.00% | ||
2023 | 0.00% | ||
2022 | 0.00% | ||
2021 | -99.99% | ||
2020 | +177.78% | ||
2019 | -91.68% | ||
2018 | -87.31% | ||
2017 | +285.79% | ||
2016 | +129.73% | ||
2015 | -67.93% | ||
2014 | +525.00% | ||
2013 | -77.14% | ||
2012 | -11.02% |
- Stock Market
- Equities
- ATTBF Stock
- Quotes Abattis Bioceuticals Corp.